Generation Bio
GBIO
$3.17
Share price
1.93%
Change (1 day)
-29.40%
Change (1 year)
Generation Bio (GBIO) - Cash on Hand
Cash on Hand as of December 2023 : $0.26 B
According to Generation Bio
's latest financial reports the company has $0.26 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Generation Bio - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.26 B | -5.28% |
| 2022-12-31 | $0.27 B | -25.6% |
| 2021-12-31 | $0.37 B | 43.01% |
| 2020-12-31 | $0.26 B | 1640.03% |
| 2019-12-31 | $15.07 M | -79.86% |
| 2018-12-31 | $74.87 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -21.25% | 🇺🇸 USA |